Milestone highlights rapid adoption of the Galaxy System’s advanced image-guided technology, transforming lung nodule diagnosis and patient careSAN CARLOS, Calif.,…
Boston (March 24, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage…
Boca Raton, Florida, March 24, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and…
NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- “Tren-Max is the safe and legal steroid alternative to Trenbolone Acetate" Our…
KUALA LUMPUR, Malaysia, March 24, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel") (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company…
MINNEAPOLIS, March 24, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies…
– Continued progress in pivotal, adaptive Phase 3 clinical trial (the “MIRACLE” trial) toward first subject treated, on track to…
Clinical Complete Responses Observed with Single Low-Dose of Bel-sar in Patients with Intermediate and High-Risk NMIBC with Robust Cell-Mediated Immunity…
Achieves International Recognition with HIMSS Award for Excellence in Smart Healthcare TAOYUAN, March 23, 2025 /PRNewswire/ -- As the demand…
NEW YORK, March 23, 2025 /PRNewswire/ -- Today Mediplanet launches their Women in Research campaign, aimed at addressing gender disparities in the…